Active Pharmaceutical Ingredient (API) Prequalified
Bedaquiline (fumarate) manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Bedaquiline (fumarate) manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
The WHO Prequalification Assessment of Medical Devices (PQT/AMD) is seeking Request for Quotations (RFQs) from interested Notified Bodies to assist in technical documentation review activities for
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Effective 1 September 2026, WHO is expanding the scope of its prequalification programme for in vitro diagnostics (IVDs) to include:
Pyrazinamide manufactured by Resonance Specialities Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
WHO Prequalification is expanding its scope to include Interferon-Gamma Release Assays (IGRAs) and targeted Next-Generation Sequencing (tNGS) assays for tuberculosis diagnos
A 43rd invitation to manufacturers of Active Pharmaceutical Ingredients (API) to submit an Expression of Interest (EOI) for API evaluation to the WHO Prequalification of Medicine